RARasha Mahmoud Allam

Rasha Mahmoud Allam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rasha Mahmoud Allam has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unraveling mortality risks in pediatric oncology: Exploring bloodstream coinfections and inflammatory biomarkers in COVID-19

    by Rasha M. Abdel-Hamid, Rasha M. Allam, Lobna Refaat, Hend A. Nooh, Farida M. Mahmoud, Ahmed Bayoumi, Safaa S. Hassan


  • Changing patterns of bacterial profile and antimicrobial resistance in high-risk patients during the COVID-19 pandemic at a tertiary oncology hospital

    by Rasha M. Abdel-Hamid, Hadir A. El-Mahallawy, Rasha M. Allam, Mai M. Zafer, Marwa Elswify

    The widespread evolution of phenotypic resistance in clinical isolates over the years, coupled with the COVID-19 pandemic onset, has exacerbated the global challenge of antimicrobial resistance. This study aimed to explore changes in bacterial infection patterns and antimicrobial resistance during the COVID-19 pandemic. This study involved the periods before and during COVID-19: the pre-pandemic and pandemic eras. The surveillance results of bacterial isolates causing infections in cancer patients at an Egyptian tertiary oncology hospital were retrieved. The Vitek®2 or Phoenix systems were utilized for species identification and susceptibility testing. Statistical analyses were performed comparing microbiological trends before and during the pandemic. Out of 2856 bacterial isolates, Gram-negative bacteria (GNB) predominated (69.7%), and Gram-positive bacteria (GPB) comprised 30.3% of isolates. No significant change was found in GNB prevalence during the pandemic (P = 0.159). Elevated rates of Klebsiella and Pseudomonas species were demonstrated during the pandemic, as was a decrease in E. coli and Acinetobacter species (P < 0.001, 0.018, < 0.001, and 0.046, respectively) in hematological patients. In surgical patients, Enterobacteriaceae significantly increased (P = 0.012), while non-fermenters significantly decreased (P = 0.007). GPB species from either hematological or surgical wards exhibited no notable changes during the pandemic. GNB resistance increased in hematological patients to carbapenems, amikacin, and tigecycline and decreased in surgical patients to amikacin and cefoxitin (P < 0.001, 0.010, < 0.001, < 0.001, and 0.016, respectively). The study highlights notable shifts in the microbial landscape during the COVID-19 pandemic, particularly in the prevalence and resistance patterns of GNB in hematological and surgical wards.


  • Uptake and safety of COVID 19 vaccine among female breast and gynecological cancer patients’, A single Egyptian center experience

    by Rasha Mahmoud Allam, Omnia Mohamed, Youstina Elamir, Mohamed Rahouma, Hala Aziz Shokralla

    Cancer patients, such as those with gynecological and breast malignancies, are at a higher risk of COVID-19 infection and severe illness. However, there is limited research on the acceptance and safety of COVID-19 vaccines, specifically in this population.Methods: We conducted a cross-sectional study involving 370 female breast and gynecological cancer patients. Data were collected on comorbidities, cancer diagnosis and stage, treatment modalities, COVID-19 infection history, severity, timing of infection in relation to chemotherapy, COVID-19 vaccination status, and vaccine side effects.Results: Among the study population, 40.3% have been received the COVID-19 vaccine, 52.2% postponed it, and 7.6% were refusing vaccination. Sinovac vaccine was the most commonly received in the chemotherapy group (56%), followed by Pfizer and AstraZeneca (18.7% each), and Sputnik and Johnson (1.3% and 5.3%, respectively). Patients with a higher level of education were more likely to refuse vaccination. Refusal rate to COVID-19 vaccine was higher in gynecological malignancy cases than female breast cancer cases (72.97% vs. 56.42%, p-value = 0.009). Vaccine side effects were reported in varying percentages, with AstraZeneca and Pfizer having the highest rates (41.7% and 33.3%, respectively), while 95.6% of Sinovac receiver reported no side effects (p < 0.001). Cases with Gynecological malignancies had an increased risk of developing side effects post-COVID-19 vaccination (29.2%, p-value = 0.018, Odds Ratio 3.54, 95% CI 1.240-10.147).Conclusion: Our findings highlight a higher vaccination refusal rate between elderly patients with advanced stage gynecological cancers. However no major safety concerns associated with receiving COVID-19 vaccination during chemotherapy treatment.

  • Open Access

    Exploring The Prognostic Significance of Lymphoma in Colon and Rectum, National Cancer Institute Experience, Egypt

    by Mohamed Atef ElKordy, Anthony Nozhy Abd ElMesseh, Ahmed Hussein ElGammal, Rasha Mahmoud Allam, Mohammed Fouad Taher

    Background: Colorectal cancer is one of the commonest types of malignancies. Lymphoma is a rare occurrence in this population, with adenocarcinoma constituting the majority of cases. Few publications have analysed the clinico-pathological behaviour of colorectal lymphoma (CL). Both the effect of systemic therapy in these cases and the significance of surgical resection of these tumours remain unclear. Objective: The aim of the current study is to address CL from the perspectives of demographic, clinical characteristics, diagnosis and treatment, as well as studying prognosis. Patients and methods: The current retrospective cohort study included all cases diagnosed with CL and managed at the National Cancer Institute, Cairo University, during the period from 2010 to 2021. The data included demographic, clinical presentation, investigation used and their results, treatment modalities used, and prognosis. Results: Throughout the durationof the study, 49 patients were diagnosed with CL and treated in the National Cancer Institute. Patients’ ages ranged between 2 and 70 years, with a median of 5 years. Burkitt lymphoma was the most common type (71%). Most of the cases (63.3%) were aroused in ascending colon. Early stages (Stages I and II) accounted for 81.6% of the cases. Before chemotherapy, 32 cases (65.3%) underwent surgical resection. The absence of B symptoms, Hg ≥10 gm/dl, and surgically treated cases were associated with a favourable prognosis. Conclusion: The incidence of lymphoma affecting thecolon and rectum is uncommon. Patients’ ages upon presentation vary, and it typically originates in the right colon. In combination with systemic therapy, surgical excision of the tumour appears to improve survival in the early stages.

  • Open Access

    Prognosis and outcomes of management of gastric adenocarcinoma at or below the age of 40 years; NCI experience

    by Mohamed Atef ElKordy, Anthony Nozhy Abd ElMesseh, Rasha Mahmoud Allam, Abd AlWahab Raafat Abd AlWahab

    Background: Gastric cancer has long been assumed to be more advanced and has a worse prognosis in younger people than in older ones. This assumption, however, has never been validated, most likely attributable to the lack of patient numbers for a stage-by-stage survival comparison. Objectives: To present NCI, Cairo University experience in managing young patients (≤ 40 years) with gastric adenocarcinoma Patients and methods: Retrospective cohort study included all cases diagnosed in NCI with gastric adenocarcinoma at or below the age of 40 years in the period from 2010 to 2021. The data included demographic attributes, clinical presentation, investigations and results, adopted treatment modalities, and prognosis of these cases. Results: During the period of the study,30 cases of gastric adenocarcinoma with ages of around 40 years or less have been diagnosed and managed in NCI. Most cases presented in an advanced stage as stage 4 represented 46.7% (14 cases). Seventeen cases (56.7%) underwent surgical exploration, where chemotherapy was taken for twenty-six cases (86.7%). The overall survival showed that patients presented with advanced stage, had omental deposits or ascites had a worse prognosis (P-value = 0.001, <0.001ز Conclusion: Gastric Cancer is aggressive in young age and presents mainly in advanced stage. In terms of overall survival, patients benefit significantly from combined treatment modalities (chemotherapy and surgical resection) compared to receiving only one treatment option.

  • Open Access

    Conventional peritoneal cytology lacks the prognostic significance of detecting local or peritoneal recurrence in colorectal cancer: An Egyptian experience

    by Mohamed Shalaby, Tarek S El Baradie, Mohamed Salama, Hebat A M Shaaban, Rasha M Allam, Ehab O.A. Hafiz, Mohamed Aly Abdelhamed, Amr Attia

    Background and Aim: Colorectal cancer (CRC) accounts for over 8% of all deaths each year, with 1.2 million new cases diagnosed annually worldwide. It represents the seventh most common cancer in Egypt. Early detection of peritoneal metastasis is a major challenge in such cases. It helps with the decision of the immediate application of intraperitoneal chemotherapy after resection. Meta‐analysis studies reported contrast evidence for a possible prognostic role of intraperitoneal free cancer cells (IPCCs) in peritoneal recurrence and survival after curative resection. In this work, we aim to evaluate the prevalence and impact of detecting free malignant cells in peritoneal fluid on survival and local recurrence and to estimate the incidence of peritoneal carcinomatosis (PC) during follow up.Methods: Design: This was a prospective cohort study. Settings: From June 2016 to December 2018, samples were collected from 104 patients who underwent abdominal surgery for colorectal cancer in the Egyptian National Cancer Institute. A total of 96 Egyptian CRC patients who underwent curative resection were enrolled. Intraoperative peritoneal lavage was performed to detect IPCC by conventional cytology. Patients with no residual tumor after surgery and no evidence of PC were followed up for a median 14 months. The cumulative 12‐month overall survival rate for patients with IPCC was 100% versus 86% for patients with negative cytology.Results: Our results demonstrated that the prevalence of IPCC in the peritoneal lavage was 11.5%. Peritoneal and local recurrence occurred at a higher rate in patients with cytology positive lavage (9.1% vs 6.3% and 9.1% vs 3.8%, respectively), although this was statistically insignificant. Distant metastasis occurred significantly in patients with positive cytology (45.5% vs 8.9%) with P‐value <0.001.The conventional cytology technique has a high specificity but less sensitivity.Conclusions: The presence of IPCC using conventional cytology was not an independent prognostic factor for the development of PC or survival.


  • Open Access

    Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)

    by Mahitab Ibrahim Eltohamy, Omnia Mohammed Badawy, Naglaa El Kinaai, Iman Loay, Hanan Ramadan Nassar, Rasha Mahmoud Allam, Mona Ali Sakr

    Objective: Triple negative breast cancer is an aggressive variant of breast cancer; it forms about 15% of breastcancer cases. It lacks the responsiveness to hormonal and targeted therapies. Anthracyclines remain the treatment optionfor these patients. Anthracyclines are cardiotoxic, so predicting sensitivity of response by biological predictors mayhave a role in selecting suitable candidates for these drugs. Material and methods: This study included 50 TNBCcases, from National Cancer Institute, Cairo University(NCI-CU), Egypt, who underwent surgery and received adjuvantchemotherapy. Archived blocks were obtained and immunostaining for Ki-67 LI and Fluorescent In situ Hybridization(FISH) technique to assess TOP2A gene copy number and chromosome 17CEP status were done. Analysis of associationbetween TOP2A alterations and CEP17 polysomy as well as Ki-67 LI with other clinicopathological parameters wasdone. Associations between the biological markers and event free survival (EFS) and overall survival (OS), were alsoperformed. Results: TOP2A alteration was seen in 9/50 cases (5 amplified and 4 deleted). CEP17 Polysomy was detectedin 14% of cases. Most of patients (80%) showed Ki-67 LI ≥20%. There was a significant association between TOP2Agene and CEP17 status. Outcome was better with abnormal TOP2A gene status and CEP17 polysomy, radiotherapyand combined anthracyclines and taxanes in the adjuvant setting, however P-values were not significant. Conclusion:TOP2A gene alterations and CEP17 polysomy may have prognostic and predictive role in TNBC treated with adjuvantAnthracyclines.


  • Open Access

    Assessment of Statistical Methodologies and Pitfalls of Dissertations Carried Out at National Cancer Institute, Cairo University

    by Rasha M Allam, Maissa K Noaman, Manar M Moneer, Inas A Elattar

    Purpose: To identify statistical errors and pitfalls in dissertations performed as part of the requirements for the Medical Doctorate (MD) degree at the National Cancer Institute (NCI), Cairo University (CU) to improve the quality of medical research. Methods: A critical assessment of 62 MD dissertations conducted in 3 departments at NCI, CU, between 2009 and 2013 was carried out regarding statistical methodology and presentation of the results. To detect differences in study characteristics over time, grouping was into two periods; 2009-2010 and 2011-2013. Results: Statistical methods were appropriate in only 13 studies (24.5%). The most common statistical tests applied were chi-square, log-rank, and Mann-Whitney tests. Four studies estimated sample size and/or power. Only 37.1% and 38.7% of dissertation results supported aims and answered the research questions, respectively. Most of results were misinterpreted (82.3%) with misuse of statistical terminology (77.4%). Tabular and graphical data display was independently informative in only 36 dissertations (58.1%) with accurate titles and labels in only 17 (27.4%). Statistical tests fulfilled the assumptions only in 29 studies; with evident misuse in 33. Ten dissertations reported non-significance regarding their primary outcome measure; the median power of the test was 35.5% (range: 6-60%). There was no significant change in the characteristics between the time periods. Conclusion: MD dissertations at NCI have many epidemiological and statistical defects that may compromise the external validity of the results. It is recommended to involve a biostatistician from the very start to improve study design, sample size calculation, end points estimation and measures.